We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Companies Should Track All Marketing to Build Defense Against Future Suits
Companies Should Track All Marketing to Build Defense Against Future Suits
A rise in whistleblower lawsuits involving off-label marketing of medical devices has sparked increased scrutiny by the FDA, and the suits are not likely to stop anytime soon, experts say.